Insights

Innovative Product Launches SEQENS' recent launch of PeptiCode HP-9 and AdvensProtect 2-EHG Green highlights its focus on cutting-edge biotech solutions and biobased skincare ingredients, presenting opportunities to collaborate on advanced formulations and sustainable products.

Strategic Market Movements The sale of Botanical Actives and IVD activities to Solabia indicates a strategic refocus on core pharmaceutical and specialty ingredient markets, opening avenues to target their remaining segments or complement their portfolio with tailored ingredient solutions.

Global Presence & R&D Focus With operations across Europe, North America, and Asia and significant R&D capabilities, SEQENS is positioned to expand its innovation pipeline, making it a prime partner for custom ingredient development and technology licensing opportunities.

New Leadership, Growth Opportunities The appointment of Pascal Villemagne as CEO signals growth ambitions and strategic shifts, providing an entry point to offer scalable services, supply chain enhancements, or digital transformation solutions to support their expansion plans.

Market Engagement Participation in key industry events like InCosmetics Asia and PCHI Guangzhou demonstrates SEQENS' commitment to market engagement and innovation, which can be leveraged for targeted outreach on novel ingredients, formulations, and partnership opportunities.

SEQENS Tech Stack

SEQENS uses 8 technology products and services including Zymewire, ISO 14644, Microsoft SQL Server, and more. Explore SEQENS's tech stack below.

  • Zymewire
    Advanced Analytics And Data Science
  • ISO 14644
    Certificates
  • Microsoft SQL Server
    Database
  • Microsoft Access
    Database Management Software
  • Ennov
    Enterprise Content Management
  • HubSpot
    Marketing Automation
  • Cegid
    Retail Operations Software
  • SpendMap
    Sales

Media & News

SEQENS's Email Address Formats

SEQENS uses at least 1 format(s):
SEQENS Email FormatsExamplePercentage
First.Last@seqens.comJohn.Doe@seqens.com
89%
FLast@seqens.comJDoe@seqens.com
10%
First.L@seqens.comJohn.D@seqens.com
1%

Frequently Asked Questions

Where is SEQENS's headquarters located?

Minus sign iconPlus sign icon
SEQENS's main headquarters is located at 21 Chemin de la Sauvegarde Écully, Auvergne-rhône-alpes 69130 France. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is SEQENS's official website and social media links?

Minus sign iconPlus sign icon
SEQENS's official website is seqens.com and has social profiles on LinkedInCrunchbase.

What is SEQENS's NAICS code?

Minus sign iconPlus sign icon
SEQENS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SEQENS have currently?

Minus sign iconPlus sign icon
As of May 2026, SEQENS has approximately 1.3K employees across 4 continents, including EuropeAsiaNorth America. Key team members include Ceo: P. C.Chief Procurement Officer: C. D.Chief Financial Officer: M. D. R.. Explore SEQENS's employee directory with LeadIQ.

What industry does SEQENS belong to?

Minus sign iconPlus sign icon
SEQENS operates in the Pharmaceutical Manufacturing industry.

What technology does SEQENS use?

Minus sign iconPlus sign icon
SEQENS's tech stack includes ZymewireISO 14644Microsoft SQL ServerMicrosoft AccessEnnovHubSpotCegidSpendMap.

What is SEQENS's email format?

Minus sign iconPlus sign icon
SEQENS's email format typically follows the pattern of First.Last@seqens.com. Find more SEQENS email formats with LeadIQ.

When was SEQENS founded?

Minus sign iconPlus sign icon
SEQENS was founded in 2003.

SEQENS

Pharmaceutical ManufacturingAuvergne-rhône-alpes, France1001-5000 Employees

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. 

The group operates 15 manufacturing sites and 5 R&D centers in Europe, North America and Asia. 2,700 employees contribute to the success of SEQENS, among which 300 scientists, engineers and experts who develop tailor-made solutions for our customers.

SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

Section iconCompany Overview

Headquarters
21 Chemin de la Sauvegarde Écully, Auvergne-rhône-alpes 69130 France
Website
seqens.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
1001-5000

Section iconFunding & Financials

  • $100M$250M

    SEQENS's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    SEQENS's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.